February 03, 2016
1 min read
Save

Patients with OA, certain genotypes had more pain variability

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

More variability in day-to-day pain and exacerbation of pain after daily physical activity was experienced among patients with osteoarthritis and certain genotypes for catechol-O-methyltransferase and mu-opioid receptor compared with patients who had other genotypes, according to results.

Using handheld computers, 120 patients with knee osteoarthritis (OA) reported on their pain three times a day during 22 days. Patients also wore an accelerometer to capture daily physical activity. Researchers examined the magnitude of within-person variability in pain by genetic group using multilevel modelling, as well as whether lagged, within-patient associations between level of activity in the afternoon and knee pain at the end of the day were moderated by between-patient differences in genotype.

Results showed patients with two copies of the Asn40 allele of mu-opioid receptor had the greatest day-to-day pain variability, while patients with the Val/Val genotype of catechol-O-methyltransferase had the greatest pain variability, as well as the greatest increase in pain as a result in physical activity. Researchers found consistencies between a similar pattern of findings across bi-directional lags with a negative feedback loop between daily physical activity and pain according to genotype. When comparing patients according to catechol-O-methyltransferase or mu-opioid receptor, results showed no significant between-person differences for daily pain. – by Casey Tingle

Disclosure: The researchers report no relevant financial disclosures.